Stemmer Imaging significantly exceeds pre-Corona sales
Stemmer Imaging's revenue and earnings in fiscal 2021 are significantly above Corona year 2020 and also above pre-Corona year 2019, the machine vision integrator reports, citing preliminary figures.
According to preliminary figures, Stemmer Imaging generated new records in terms of sales and operating profit (Ebitda): Sales increased by 26 percent to around 130 million euros. Compared to the pre-Corona year 2019, there is still an increase of just under 10 percent (2019 sales: around 103 million euros).
Operating profit (Ebitda) shot up by almost 141 percent, landing at 17.4 million euros. Compared to 2019, this was an increase of 61 percent.
The record result was supported by strong market momentum and successes in strategic end markets such as e-mobility and sports & entertainment.In addition, Stemmer Imaging managed to leverage its focused positioning despite global supply constraints.
Change in accounting method for trading standard software licenses
Stemmer Imaging changed its accounting method for trading standard software licenses in the annual and consolidated financial statements for the fiscal year ending December 31, 2021. The reason for this is a specification of the International Financial Reporting Standards (IFRS) . According to this revaluation, Stemmer classifies the aforementioned sales as agent and therefore reports them in sales only in the amount of the gross margin achieved. The revaluation therefore increased sales growth by 0.3 percentage points compared to the previous valuation.
